96894 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Sub-classes:PARTICLE-BASED SEPARATION OF EXTRACELLULAR VESICLES
#2KARYOCREATE (KARYOTYPE CRISPR ENGINEERED ANEUPLOIDY TECHNOLOGY)
#3Nanobody platform, Peptide-modified Nanobody, Production Process, and Use
#4METHOD FOR PRODUCING EXTRACELLULAR VESICLES CONTAINING BIOACTIVE SUBSTANCE
#5CHIMERIC CYTOKINE RECEPTOR
#6Rodenticide
#7DENDRITIC CELL ASGPR TARGETING IMMUNOTHERAPEUTICS FOR MULTIPLE SCLEROSIS
#8METHODS FOR MAKING DISULFIDE-RICH PEPTIDES AND PROTEINS
#9FUSION PROTEINS FOR INHIBITING ANGIOGENESIS
#10PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING
#11RABIES VIRAL GLYCOPROTEIN COMPOSITIONS AND METHODS OF USE
#12NOVEL COMPOSITIONS WITH BRAIN-SPECIFIC TARGETING MOTIFS AND COMPOSITIONS CONTAINING SAME
#13PROTEIN WITH ACTIVITY OF INHIBITING ANGIOGENESIS AND INFLAMMATION, AND PREPARATION METHOD THEREOF
#14FUSION PROTEIN CONTAINING TISSUE PLASMINOGEN ACTIVATOR OR ITS VARIANT AND TARGETING INTEGRIN ALPHA(IIB)BETA(3) AND THE APPLICATION THEREOF
#15REVERSE GENETIC SYSTEM FOR SARS-COV-2
#16Bioactive peptides derived from snakes
#17ARC-BASED CAPSIDS AND USES THEREOF
#18EXENDIN-4 PEPTIDE ANALOGS
#19A DISINTEGRIN AND METALLOPROTEINASE WITH A THROMBOSPONDIN TYPE I MOTIF, MEMBER 13 (ADAMTS-13) MUTANTS, COMPOSITIONS AND THERAPEUTIC METHODS THEREOF
#20VASOPRESSIN-2 RECEPTOR ANTAGONIST PEPTIDES AND USES THEREOF
#21RECOMBINANT POLYPEPTIDES FOR MEMBRANE FUSION AND USES THEREOF
#22Chimeric transmembrane protein comprising antibody dimerization domains and a type I cytokine receptor endodomain, encoding nucleic acids thereof and methods of use thereof
#23NOVEL THERAPEUTICAL TOOLS AND METHODS USING TEMPERATURE-SENSITIVE RECEPTORS FOR TREATING BLINDNESS
#24ARC-BASED CAPSIDS AND USES THEREOF
#25ANTIMICROBIAL PEPTIDES
#26DEGRADABLE MULTI-ARM POLYETHYLENE GLYCOL DERIVATIVE
#27Prohemostatic proteins for the treatment of bleeding
#28COMPOSITIONS AND METHODS TO BLOCK AND BIND CXCR4 TO MODULATE CELLULAR FUNCTION
#29PPR PROTEIN CAUSING LESS AGGREGATION AND USE OF THE SAME
#30Screening for Inhibitors of Prostaglandin E Synthase 3 Useful for Treatment of Prostate Cancer
#31ARC-BASED CAPSIDS AND USES THEREOF
#32Bioactive peptides derived from snakes
#33Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosis
#34Endogenous Gag-based capsids and uses thereof
#35Endogenous Gag-based capsids and uses thereof
#36Methods of inhibiting integrin α9β1 activity
#37Methods for treating cancer or modulating T cells or NK cells in a subject with cancer by administering cells comprising chimeric cytokine receptors
#38Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins
#39NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION
#40Oral Gene Carrier And Use Thereof
#41Peptide sequence of a guide protein for the production of a peptide of interest, an expression vector, a host cell, and a method for the production of a peptide of interest
#42Highly Versatile Method of Presenting Cyclic Peptide on Protein Structure
#43USE OF CEREBROLYSIN
#44METHODS FOR TREATING DIABETES AND REDUCING BODY WEIGHT
#45Fusion proteins for inhibiting angiogenesis
#46Disintegrin variants and uses thereof
#47Prohemostatic proteins for the treatment of bleeding
#48Prohemostatic proteins for the treatment of bleeding
#49PRODUCTION OF POLYSIALYLATED POLYPEPTIDES IN PLANTS AND PLANT CELLS
#50DNA and method for preparing heterodimer snake venom protein
#51CONTROL OF VIRAL AND BACTERIAL INFECTION BY ANTIMICROBIAL PEPTIDES RETROCYCLIN AND/OR PROTEGRIN EXPRESSED IN CHLOROPLASTS
#52Disintegrin variants and pharmaceutical uses thereof
#53METHODS AND COMPOSITIONS FOR MODIFYING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR ACTIVITY
#54HYBRID CARRIERS FOR NUCLEIC ACID CARGO
#55Recombinant polypepties for membrane fusion and uses thereof
#56COMPOSITION AND METHOD FOR ORAL DELIVERY OF STABLE FORMULATIONS OF COBRA VENOM
#57Lebecetin, a C-type lectin, as neovascularization inhibitor
#58GDF15 fusion proteins and uses thereof
#59NOVEL MONOMERIC YELLOW-GREEN FLUORESCENT PROTEIN FROM CEPHALOCHORDATE
#60Fusion protein comprising antifreeze protein and human epidermal growth factor with increased anti-oxidant activity and skin cell proliferation effect and cosmetic composition for anti-wrinkle comprising the same as effective component
#61Fusion proteins for inhibiting angiogenesis
#62ANTIMICROBIAL AGENTS AGAINST SALMONELLA BACTERIA
#63Chimeric cytokine receptors and encoding nucleic acids
#64METHODS FOR TREATING DIABETES AND REDUCING BODY WEIGHT
#65Polypeptides, nucleic acids and uses thereof
#66Chimeric cytokine receptors and encoding nucleic acids
#67PEPTIDE HAVING CELL MEMBRANE PENETRATING ACTIVITY
#68Adeno-associated viruses engineered for selectable tropism
#69Murine, chimeric, humanized or human anti-TNF-alpha antibodies
#70FUSION PROTEINS FOR INHIBITING ANGIOGENESIS
#71Nuclease-mediated regulation of gene expression
#72Protamine in treatment of neuronal injuries
#73Method for treating vascular stenosis or occlusive disease due to thrombi by administering a saxatilin-fc fusion protein
#74Electron spin labeled ice binding compounds used for carrying paramagnetic centers for dynamic nuclear polarization
#75Compositions and methods for peptide expression and purification using a type III secretion system
#76GDF15 fusion proteins and uses thereof
#77Function suppression type of genetically-modified rhodocytin mutant
#78Murine, chimeric, humanized or human anti-IL-6 antibodies
#79Disintegrin variants and pharmaceutical uses thereof
#80Fusion Protein Suitable for Measurement of Autophagy, Nucleic Acid Encoding Said Fusion Protein, and Use of These
#81Polypeptide binding to extracellular domain of epidermal growth factor receptor
#82SAXATILIN-FC FUSION PROTEIN AND USE THEREOF
#83Peptide having cell membrane penetrating activity
#84BISPECIFIC ANTIBODIES THAT NEUTRALIZE BOTH TNF-ALPHA AND IL-6: NOVEL THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASE
#85Polypeptides, nucleic acids and uses thereof
#86Polynucleotide, polypeptide with immunosuppressive activity, expression cassette, expression vector, host cell, pharmaceutical composition, methods for producing a polypeptide with immunosuppressive activity and for preventing or treating conditions that require immunosuppression, and use of a polypeptide
#87DENDRITIC CELL ASGPR TARGETING IMMUNOTHERAPEUTICS FOR MULTIPLE SCLEROSIS
#88Methods of treating cancers with peptide-based modulators
#89Protamine in treatment of neuronal injuries
#90Methods for treating diabetes and reducing body weight
#91Method of modulating the activity of a nucleic acid molecule
#92Electron spin labeled ice binding compounds used for carrying paramagnetic centers for dynamic nuclear polarization
#93Method for Diagnosing or Predicting a Non Syndromic Autosomal Recessive Optic Atrophy, or a Risk of a Non Syndromic Autosomal Recessive Optic Atrophy
#94Potent and selective inhibitors of Nav1.7
#95Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists
#96Peptide antagonists of the vasopressin-2 receptor
#97Compositions and methods for peptide expression and purification using a type III secretion system
#98METHOD TO IMPROVE PHARMACOKINETICS OF DRUGS
#99Pan-antiviral peptides and uses thereof
#100Alteration of cell membrane for new functions using IL-2 and streptavidin
#101FUSION PROTEINS COMPRISING IGG2 HINGE DOMAINS
#102Disulphide bond-stabilized functional soluble MHC class II heterodimers
#103Recombinant polypeptides for membrane fusion and uses thereof
#104Selective αβreceptor peptide antagonist for therapeutic and diagnostic applications
#105Water-soluble polypeptides comprised of repeat modules, method for preparing the same and method for a target-specific polypeptide and analysis of biological activity thereof
#106Vesiculins
#107Monomeric yellow-green fluorescent protein from cephalochordate
#108FLUORESCENT PROTEINS AND GENES ENCODING THEM
#109Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same
#110Peptides which have analgesic effects and which inhibit ASIC channels
#111Method for treating diabetes
#112Disulphide bond-stabilized functional soluble MHC class II heterodimers
#113Fusion protein of Exendin-4 and its analog, preparation method and use thereof
#114Targeting the neuromuscular junction for treatment
#115Anti-angiogenic peptides and their uses
#116METHOD OF DELIVERING RNA INTERFERENCE AND USES THEREOF
#117Alteration of cell membrane for new functions
#118NOVEL ANTI-MICROBIAL PEPTIDOMIMETIC COMPOUNDS AND METHODS TO CALCULATE ANTI-MICROBIAL ACTIVITY
#119PROTEINACEOUS COMPOUNDS AND USES THEREFOR
#120Method of detection using antibodies that specifically bind hedgehog-derived polypeptides
#121Method for Diagnosing or Predicting a Non Syndromic Autosomal Recessive Optic Atrophy, or a Risk of a Non Syndromic Autosomal Recessive Optic Atrophy
#122Use of Vgll3 activity modulator for the modulation of adipogenesis
#123N-terminus conformationally constrained GLP-1 receptor agonist compounds
#124Antibody fusion-mediated plant resistance against Oomycota
#125Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies
#126CONTROL OF VIRAL AND BACTERIAL INFECTION BY ANTIMICROBIAL PEPTIDES RETROCYLIN AND/OR PROTEGRIN EXPRESSED IN CHLOROPLASTS
#127Method of expressing proteins with disulfide bridges with enhanced yields and activity
#128BIOCIDAL FUSION PEPTIDE COMPRISING LL-37
#129Snake factor V and methods of use thereof as a procoagulant
#130Methods for treating diabetes and reducing body weight
#131CECROPIN-MAGAININ HYBRID PEPTIDES
#132GAMMACARBOXYGLUTAMATE-RICH PROTEIN, METHODS AND ASSAYS FOR ITS DETECTION, PURIFICATION AND QUANTIFICATION AND USES THEREOF
#133IDENTIFICATION OF A NOVEL CYSTEINE-RICH CELL PENETRATING PEPTIDE
#134Methods of treating αvβ3 integrin-associated diseases by administering polypeptides selective for αvβ3 integrin
#135REGULATION OF LUNG TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO
#136Postsynaptically targeted chemodenervation agents and their methods of use
#137TREATMENT OF PARKINSON'S DISEASE
#138Methods for regulation of stem cells
#139Treatment of parkinson's disease via administration of GLI-1 protein
#140Identification of a novel cysteine-rich cell penetrating peptide
#141METHODS AND COMPOSITIONS FOR INCREASING MEMBRANE PERMEABILITY
#142Methods of treating pancreatic or liver cancer using hedgehog antagonists
#143Antibodies that specifically bind hedgehog-derived polypeptides
#144Vesiculins
#145Preparation of low bleeding anticoagulant fusion protein and its use
#146N-terminal modified exendin-4
#147Method of modulating the activity of a nucleic acid molecule
#148PEPTIDE HAVING CELL MEMBRANE PENETRATING ACTIVITY
#149Method of producing biologically active polypeptide having insulinotropic activity
#150Antimicrobial and anticancer lipopeptides
#151Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
#152Preparation of low bleeding anticoagulant fusion protein and its use
#153THERAPEUTIC USES OF BETA-ANTAGONISTS
#154AGENTS FOR TREATING MALIGNANT MESOTHELIOMA
#155Anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity
#156Fluorescent proteins and genes encoding them
#157NOVEL SNAKE TOXIN
#158METHODS FOR TREATING DIABETES AND REDUCING BODY WEIGHT
#159Analog compounds of analgesic peptides derived from the venom of snakes, their uses, compositions, methods of preparation and purification
#160Antibodies that specifically bind hedgehog-derived polypeptides
#161NOVEL ANTICOAGULANT POLYPEPTIDES AND COMPLEX
#162Alteration of cell membrane with FasL
#163Hydrophobically-modified protein compositions and methods
#164VESICULINS
#165Prophylactic/Therapeutic Agent for Cancer
#166NOVEL GLP-1 ANALOGUES LINKED TO ALBUMIN-LIKE AGENTS
#167Bioactive peptides
#168Methods and Compositions for Increasing Membrane Permeability
#169Method of inducing and maintaining neuronal cells
#170Immunokine composition and method
#171Selective αvβ3 receptor peptide antagonist for therapeutic and diagnostic applications
#172Pharmaceutical Compositions Preparation of Peptides, Secreted by the Snake Venom Glands, Particularly of Bothrops Jararaca, Vasopeptidases Inhibitors, Evasins, Their Analogues, Derivatives and Products Associated, Thereof, for Development of Applications and Use in Chronic-Degenerative Diseases
#173Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
#174Disintegrin variants and their use in treating osteoporosis-induced bone loss and angiogenesis-related diseases
#175Methods, kits and compositions comprising crotamine
#176Treatment of parkinson's disease and related disorders
#177Pan-antiviral peptides
#178Chimeric proteins with natriuretic activity
#179Method of delivering RNA interference and uses thereof
#180Hedgehog Signaling in Prostate Regeneration Neoplasia and Metastasis
#181Production of modified neurotoxins
#182Animal Model of Prostate Cancer and Use Thereof
#183Polypeptide Inducing the Secretion of Angiopoietin
#184Two synthetic peptides for treatment and prevention of cancers
#185Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
#186Vertebrate embryonic pattern-inducing proteins, and uses related thereto
#187Allergenic proteins and peptides from dog dander and uses therefor
#188Morphogen compositions and methods of use thereof to treat heart disorders
#189Modulating cancer cell characteristics
#190Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
#191Novel GLP-1 analogues linked to albumin-like agents
#192Antimicrobial and anticancer lipopeptides
#193Hedgehog interacting proteins and uses related thereto
#194Methods and compositions for treatment of arthritis and cancer
#195Modulation of hedgehog-mediated signaling pathway
#196Method for engineering a protein by in vitro coevolution
#197Methods for regulation of stem cells
#198Therapeutic and prophylactic agents and methods of using the same
#199Active modified hedgehog proteins
#200Methods to stimulate insulin production by pancreatic β-cells
#201Melusin a muscle specific protein, as a drug target for prevention and treatment of heart failure
#202Allergenic proteins and peptides from dog dander and uses therefor
#203Anti-cancer agents comprising disintegrin genes and the treating methods
#204Short chain neurotoxin from sea snake-and genes encoding the neurotoxin
#205Hydrophobically-modified protein compositions and methods
#206Protamine fragment compositions and methods of use
#207Zinc finger protein derivatives and methods therefor
#208Sex- specific selection of sperm from transgenic animals
#209Phospholipase A-inhibitory peptide with anti-arthritic and neuroprotective activities
#210Protein derived from and process preparing the same
#211Vertebrate embryonic pattern-inducing proteins and uses related thereto